Compare · BIOX vs NITO
BIOX vs NITO
Side-by-side comparison of Bioceres Crop Solutions Corp. (BIOX) and N2OFF Inc. (NITO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIOX and NITO operate in Agricultural Chemicals (Industrials), so they compete in similar markets.
- BIOX carries a market cap of $502.3M.
- Over the past year, BIOX is down 83.2% and NITO is down 68.8% - NITO leads by 14.4 points.
- BIOX has more recent analyst coverage (7 ratings vs 0 for NITO).
- Company
- Bioceres Crop Solutions Corp.
- N2OFF Inc.
- Price
- $0.28-12.72%
- $1.25+32.98%
- Market cap
- $502.3M
- -
- 1M return
- -25.41%
- -15.54%
- 1Y return
- -83.17%
- -68.75%
- Industry
- Agricultural Chemicals
- Agricultural Chemicals
- Exchange
- AMEX
- NASDAQ
- IPO
- News (4w)
- 0
- 0
- Recent ratings
- 7
- 0
Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. The company operates through three segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment develops and commercializes seed technology, biotechnological events, germplasm, and seed treatments. The Crop Protection segment develops, produces, and markets adjuvants, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. In addition, the company offers HB4, a drought tolerant seed technology program. It operates in Argentina, Austria, Bolivia, Brazil, Lebanon, the United States, Italy, Paraguay, the United Kingdom, South Africa, France, Canada, Ukraine, Uruguay, and internationally. The company is headquartered in Rosario, Argentina. Bioceres Crop Solutions Corp. is a subsidiary of Bioceres LLC.
Latest BIOX
- SEC Form 6-K filed by Bioceres Crop Solutions Corp.
- SEC Form 6-K filed by Bioceres Crop Solutions Corp.
- Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results
- Bioceres Crop Solutions to Host Fiscal Fourth Quarter and Full Year 2026 Financial Results Conference Call on Tuesday, September 15, 2026 at 8:30 a.m. Eastern Time
- Amendment: CEO Trucco Federico gifted 130,000 units of Ordinary Shares (SEC Form 4)
- CEO Trucco Federico gifted 150,000 units of Ordinary Shares (SEC Form 4)
- SEC Form 4 filed by CFO Simmermacher Ezequiel
- SEC Form 6-K filed by Bioceres Crop Solutions Corp.
- SEC Form 6-K filed by Bioceres Crop Solutions Corp.
- SEC Form 3 filed by new insider Duraiswami Narain
Latest NITO
- SEC Form PRE 14A filed by N2OFF Inc.
- N2OFF Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities
- N2OFF Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure
- N2OFF Announcing Corporate Rebranding as Nexentis Technologies - Innovative AI and Data Driven Computational Biotech Company
- MitoCareX Bio Reports Successful Results in Vitro: MITOLINE™-Powered Small Molecules Show Anti-Inflammatory Potential for Metabolic Syndrome-Related Diseases
- Chief Executive Officer Palach David was granted 100,000 units of Restricted Shares of Common Stock (SEC Form 4)
- Controller Zakai Shlomo was granted 50,000 units of Restricted Shares of Common Stock (SEC Form 4)
- Director Weiss Amitay was granted 116,286 units of Restricted Shares of Common Stock (SEC Form 4)
- Chief Financial Officer Barda Lital was granted 50,000 units of Restricted Shares of Common Stock (SEC Form 4)
- In Spaceflight Conditions: N2OFF's MitoCareX Bio Highlights Co-Founder's Innovative Research on Mitochondrial Carriers in Microgravity and Cosmic radiation Conditions